PTEN and renal cell carcinoma: At low levels, ROS can promote survival and proliferation, exploiting various mitogenic signaling pathways implicated in tumorigenesis (including in RCC), such as those involving phosphatase and tensin homologue (PTEN), phosphoinositide 3 (PI3)-kinase, and platelet-derived growth factor (PDGF) (108).